The Claris Lifesciences IPO is a closed mainboard Bookbuilding offer (Fresh Capital) that opened on 24 November 2010. The Claris Lifesciences IPO closed on 2 December 2010, with an issue price of ₹235 per share. The Claris Lifesciences IPO has a face value of ₹10 and a lot size of 22 shares. The Claris Lifesciences IPO is listed on 20 December 2010.
On the financial front, the Claris Lifesciences IPO reported revenue of ₹759 crore for 31-Dec-09, compared with ₹764 crore for 31-Dec-08. The Claris Lifesciences IPO PAT was ₹130 crore against ₹108 crore.
Always verify The Claris Lifesciences IPO details and GMP data with the official offer document before investing in the Claris Lifesciences IPO.
Financial Summary
Amount in ₹ Crore
Metric
31-Dec-09
31-Dec-08
31-Dec-07
Revenue
759
764
624
PAT
130
108
83
Claris Lifesciences IPO Financials FAQs
Revenue of Claris Lifesciences (Amount in ₹ Crore) — 31-Dec-09: 759; 31-Dec-08: 764; 31-Dec-07: 624. Profit after tax (PAT) — 31-Dec-09: 130; 31-Dec-08: 108; 31-Dec-07: 83.
The financials shown for Claris Lifesciences IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
